The Japanese Biochemical Society

12:45 PM - 1:45 PM

[2PL1] Tofacitinib (CP-690,550): A First-In-Class Janus Kinase (JAK) Inhibitor for the Treatment of Rheumatoid Arthritis

Flanagan Mark E. (Pfizer Worldwide Medicinal Chemistry)

tofacitinib, CP-690,550, Janus kinase, JAK/STAT, JAK pathways

Contents of this site has moved to the member page of The Japanese Biochemical Society:
You can access the abstracts without credentials by accessing them via the member page.

You need the membership number and password to access the member page. Please contact the journal office for any inquiries.

Journal Office Contact Information:
Tel:03(3815)1913 Fax:03(3815)1934